These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7577983)

  • 21. Guanidine derivatives rescue the Arg418Ala mutation of Tritrichomonas foetus IMP dehydrogenase.
    Guillén Schlippe YV; Hedstrom L
    Biochemistry; 2005 Dec; 44(50):16695-700. PubMed ID: 16342959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMP dehydrogenase : structural aspects of inhibitor binding.
    Goldstein BM; Colby TD
    Curr Med Chem; 1999 Jul; 6(7):519-36. PubMed ID: 10390598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of IMPDH by mycophenolic acid: dissection of forward and reverse pathways using capillary electrophoresis.
    Fleming MA; Chambers SP; Connelly PR; Nimmesgern E; Fox T; Bruzzese FJ; Hoe ST; Fulghum JR; Livingston DJ; Stuver CM; Sintchak MD; Wilson KP; Thomson JA
    Biochemistry; 1996 Jun; 35(22):6990-7. PubMed ID: 8679523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.
    Colby TD; Vanderveen K; Strickler MD; Markham GD; Goldstein BM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3531-6. PubMed ID: 10097070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
    McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
    Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steady-state kinetics of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus: the role of threonine-47.
    Munagala NR; Chin MS; Wang CC
    Biochemistry; 1998 Mar; 37(12):4045-51. PubMed ID: 9521725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug selectivity is determined by coupling across the NAD+ site of IMP dehydrogenase.
    Digits JA; Hedstrom L
    Biochemistry; 2000 Feb; 39(7):1771-7. PubMed ID: 10677226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase.
    Gan L; Seyedsayamdost MR; Shuto S; Matsuda A; Petsko GA; Hedstrom L
    Biochemistry; 2003 Feb; 42(4):857-63. PubMed ID: 12549902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inosine 5'-monophosphate dehydrogenase of Escherichia coli. Purification by affinity chromatography, subunit structure and inhibition by guanosine 5'-monophosphate.
    Gilbert HJ; Lowe CR; Drabble WT
    Biochem J; 1979 Dec; 183(3):481-94. PubMed ID: 44191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products.
    Wang W; Hedstrom L
    Biochemistry; 1997 Jul; 36(28):8479-83. PubMed ID: 9214292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asp338 controls hydride transfer in Escherichia coli IMP dehydrogenase.
    Kerr KM; Digits JA; Kuperwasser N; Hedstrom L
    Biochemistry; 2000 Aug; 39(32):9804-10. PubMed ID: 10933797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity chromatography on immobilised nucleotides. The synthesis, specificity and applications of immobilised inosine 5'-monophosphate.
    Clonis YD; Lowe CR
    Eur J Biochem; 1980 Sep; 110(1):279-88. PubMed ID: 6108211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential signatures of bacterial and mammalian IMP dehydrogenase enzymes.
    Zhang R; Evans G; Rotella F; Westbrook E; Huberman E; Joachimiak A; Collart FR
    Curr Med Chem; 1999 Jul; 6(7):537-43. PubMed ID: 10390599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMP dehydrogenase: the dynamics of drug selectivity.
    Hedstrom L; Gan L; Schlippe YG; Riera T; Seyedsayamdost M
    Nucleic Acids Res Suppl; 2003; (3):97-8. PubMed ID: 14510398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of human type I and type II IMP dehydrogenases.
    Carr SF; Papp E; Wu JC; Natsumeda Y
    J Biol Chem; 1993 Dec; 268(36):27286-90. PubMed ID: 7903306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic and spectroscopic studies of Tritrichomonas foetus low-molecular weight phosphotyrosyl phosphatase. Hydrogen bond networks and electrostatic effects.
    Thomas CL; McKinnon E; Granger BL; Harms E; Van Etten RL
    Biochemistry; 2002 Dec; 41(52):15601-9. PubMed ID: 12501188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ribonucleoside-5'-monophosphates with disubstituted phosphate residue do not interact with human inosine monophosphate dehydrogenase].
    Shipitsyn AV; Shirokova EA
    Bioorg Khim; 1997 Jan; 23(1):42-5. PubMed ID: 9139642
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of inosine monophosphate dehydrogenase (IMPDH) by the antiviral compound, 2-vinylinosine monophosphate.
    Pal S; Bera B; Nair V
    Bioorg Med Chem; 2002 Nov; 10(11):3615-8. PubMed ID: 12213477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monovalent cation activation in Escherichia coli inosine 5'-monophosphate dehydrogenase.
    Kerr KM; Cahoon M; Bosco DA; Hedstrom L
    Arch Biochem Biophys; 2000 Mar; 375(1):131-7. PubMed ID: 10683258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.